Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicam.
Cadel
S
S
Pharmacological and Toxicological Research Laboratories, Chiesi Farmaceutici S.p.A., Parma, Italy.
Bongrani
S
S
D000284:Administration, Oral; D000818:Animals; D003505:Cyclodextrins / Q000493:pharmacokinetics*; D003912:Dextrins / Q000493:pharmacokinetics*; D006207:Half-Life; D007408:Intestinal Absorption; D008297:Male; D010894:Piroxicam / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity; D051381:Rats; D011919:Rats, Inbred Strains; D013213:Starch / Q000493:pharmacokinetics*; D013272:Stomach Diseases / Q000139:chemically induced* / Q000503:physiopathology; D047392:beta-Cyclodextrins
D003505:Cyclodextrins; D003912:Dextrins; D047392:beta-Cyclodextrins; D010894:Piroxicam; D013213:Starch; C031215:betadex